Effect of Preoperative Olfactory Training on Postoperative Delirium in the Elderly Undergoing Orthopedic Surgeries

Preoperative Olfactory Training Reduces the Incidence of Postoperative Delirium in Elderly Patients Undergoingorthopedic Surgeries: a Prospective Randomized Controlled Clinical Study

To observe whether preoperative olfactory training can reduces the incidence of postoperative delirium in elderly patients undergoing orthopedic surgeries, a prospective randomized controlled study method will be used in this study.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

450 elderly patients undergoing orthopedic surgeries (hip or knee replacement and laminectomy) under general anesthesia or combined spinal epidural anesthesia will be selected. They will be randomly divided into control group and olfactory training group.The olfactory training group was performed 24-48h before surgery used phenylethyl alcohol (rose), phytol (press tree), citronella (lemon), eugenol (clove) 4 kinds of smell,twice a day for three days. The general condition, operation, anesthesia and hospitalization related data of the patients will be recorded.

Outcome Measures: Incidence of postoperative delirium: The 3D-CAM scores of the control group and the olfactory training group were evaluated within 1-5 days after operation.

Degree of delirium:The MDAS of the control group and the olfactory training group were evaluated within 1-5 days after operation.

Pain:The VAS of the control group and the olfactory training group were evaluated within 1-5 days after operation.

Olfactory function:The TDI scores of the control group and the olfactory training group were evaluated in 3 days before operation and 48h after operation.

Cognitive function:The MoCA scores of the control group and the olfactory training group were evaluated in postoperative 5-7 days.

Markers: Delirium related markers and inflammatory factors in bloods was detected before surgery and after anesthesia. Delirium related markers and inflammatory factors in cerebrospinal fluid was detected after spinal puncture.

Subgroup analysis: patients were divided into delirium group and non-delirium group according to whether delirium occurred, and the data of the two groups were compared, including preoperative and postoperative olfactory function TDI scores, preoperative and postoperative VAS scores, nutritional scores, activity scores, and frailty index, Carlson comorbidity index, depression, anxiety state, sleep disturbance, etc., to screen risk factors.

Study Type

Interventional

Enrollment (Estimated)

450

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Patients undergoingorthopedic surgeries (hip or knee replacement and laminectomy) under general anesthesia or combined spinal-epidural anesthesia:
  2. 65 years old ≤ age ≤ 90 years old, gender is not limited, ASA classification ≤ class III:
  3. There is no recent history of surgery, and the operation time is ≥ 2 hours.
  4. Able to communicate normally, able to cooperate and complete the cognitive function test. MMSE score >17.
  5. Patients and their families are aware of and willing to participate.

Exclusion Criteria:

  1. emergency surgery;
  2. People with brain diseases or history of brain diseases such as cerebral infarction, stroke, etc.:
  3. Have a history of neurological and psychological diseases, including Alzheimer's disease, Parkinson's, psychosis, etc.:
  4. Illiteracy, severe hearing or visual impairment;
  5. Those who have taken psychotropic drugs or abused psychotropic drugs within one month:
  6. Sinusitis, previous nasal surgery history, nasal congestion, upper respiratory tract infection in the past two weeks, previously diagnosed rhinitis and other diseases that may affect olfactory function.
  7. Patients who are allergic to pollen
  8. Patients who cannot cooperate or refuse to sign informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
The control group conducts standard preoperative preparation
Experimental: olfactory training group
The olfactory training group was performed 24-48h before surgery used phenylethyl alcohol (rose), phytol (press tree), citronella (lemon), eugenol (clove) 4 kinds of smell,twice a day for three days.
In this group, patients were performed 24-48h before surgery used phenylethyl alcohol (rose), phytol (press tree), citronella (lemon), eugenol (clove) 4 kinds of smell,twice a day for three days.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of postoperative delirium
Time Frame: Postoperative 1-5 days
The 3D-CAM scores
Postoperative 1-5 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Degree of delirium
Time Frame: Postoperative 1-5 days
Memorial delirium assessment scale(MDSA)
Postoperative 1-5 days
Olfactory function
Time Frame: postoperative 48h compared to preoperative 72h
The Sniffin' Sticks test involves testing odor for threshold and discrimination whilst blind folded and secondly odor identification. The sum of four odors responses ranges from 0-16. The sum of total score from odor Threshold, Discrimination and Identification (TDI) is a maximum of 48 points. The total score is graded as; normosmia equals or over 30.5 points, hyposmia 16.5-30 points and anosmia less than 16.5 points.
postoperative 48h compared to preoperative 72h
Cognitive function
Time Frame: postoperative 5-7 days
Total score of the Montreal Cognitive Assessment (MoCA).
postoperative 5-7 days
Postoperative pain
Time Frame: Postoperative 1-5 days
Post-operative pain, measured in visual analogue scale (VAS),0:no pian, 10:worst pain.
Postoperative 1-5 days
Delirium related markers and inflammatory factors in bloods
Time Frame: immediate post-anesthesia compared to pre-operation
These markers include:IL-6, IL-8, IL-10, TNF-α, IL-1β, CRP, N-terminal BNP, albumin, NSE, S-100B, Aβ-42 and T-tau, P-tau, S-100β
immediate post-anesthesia compared to pre-operation
Delirium related markers and inflammatory factors in cerebrospinal fluid
Time Frame: immediate post-anesthesia compared to pre-operation
These markers include:IL-6, IL-8, IL-10, TNF-α, IL-1β, albumin, NSE, S-100B, Aβ-42 and T-tau, P-tau, S-100β
immediate post-anesthesia compared to pre-operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 1, 2023

Primary Completion (Estimated)

July 1, 2025

Study Completion (Estimated)

January 1, 2026

Study Registration Dates

First Submitted

May 29, 2023

First Submitted That Met QC Criteria

June 8, 2023

First Posted (Estimated)

June 16, 2023

Study Record Updates

Last Update Posted (Estimated)

June 16, 2023

Last Update Submitted That Met QC Criteria

June 8, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Delirium

Clinical Trials on olfactory training

Subscribe